#Cobenfy
LightNews LightNews
brian215.bsky.social
I’ll bet they hate this Cobenfy ad over on the everything app.
February 5, 2026 at 11:51 PM
natrevdrugdiscov.nature.com
Cobenfy, the first drug with a new mechanism for schizophrenia in decades, is also being investigated in Alzheimer disease.

For readers interested in drugs such as this that target muscarinic acetylcholine receptors, here's a review www.nature.com/articles/s41...
rdcu.be/e1VOo
A golden age of muscarinic acetylcholine receptor modulation in neurological diseases - Nature Reviews Drug Discovery
The M1 and M4 muscarinic acetylcholine receptors represent promising therapeutic targets for Alzheimer disease and schizophrenia. However, the development of agents targeting these receptors has been ...
www.nature.com
February 3, 2026 at 5:19 PM
skektek.bsky.social
IMAGINE WHAT COULD BE- #COVFEFE!!
(Whoever named their drug #Cobenfy - LOL)
darth vader is standing in front of a man with the words i find your lack of covfefe disturbing
ALT: darth vader is standing in front of a man with the words i find your lack of covfefe disturbing
media.tenor.com
February 3, 2026 at 12:58 PM
cdarwin.c.im.ap.brid.gy
Bristol Myers Squibb, an industry stalwart in need of a hit, is betting a pill called Cobenfy can become the first approved medicine for the millions of Americans diagnosed with psychosis related to Alzheimer’s disease.
That case rests almost entirely on a single clinical trial, conducted before […]
Original post on c.im
c.im
February 2, 2026 at 4:24 PM
grotru.bsky.social
They were in hot water a month ago:
BMS' Cobenfy TV ad is latest target of FDA untitled letter spree share.google/uq2J3S2Ao4h1...
BMS' Cobenfy TV ad is latest target of FDA untitled letter spree
As the FDA steadily churns out a stream of untitled letters chastising pharmaceutical advertisers’ direct-to-consumer materials, a commercial for Bristol Myers Squibb’s Cobenfy is taking its turn i | ...
share.google
January 26, 2026 at 1:22 AM
grotru.bsky.social
While munching down a sugar bowl and drinking a 20 oz coffee at 8 pm. *Hits vape*

Teenager: "He's friggin' AI, ma!"
Ma: *starts looking up signs of schizophrenia and notices that one is believing that people aren't real" "Son, you seem manic... I'm concerned."

Another win for Cobenfy. Assholes.
January 25, 2026 at 8:47 PM
grotru.bsky.social
It'd be really cruel to find out that the Cobenfy makers used AI-generated people to market schizophrenia medication. Or they used a dude who is so mechanical that it triggers an amygdala fear response. Either way, they're jerks. Not schizophrenic; just a concerned marketer.
January 25, 2026 at 2:18 AM
chrisaikenmd.bsky.social
Cobenfy over a year in #schizophrenia (no placebo):
▪ Improvement in positive/negative symptoms
▪ Weight loss
▪ ~20% Nausea, vomit, constipation
▪ ~10% Hypertension, diarrhea, dry mouth, dizziness, headache
▪ ~5%: Dyspepsia, fatigue, sweats

pubmed.ncbi.nlm.nih.gov/41506001

#psychiatry #pmhnp
January 22, 2026 at 5:04 PM
mrbutterchicken.bsky.social
It’s absolutely wild that they advertise Cobenfy, a schizophrenia medication, on American TV. Are American schizophrenics shopping around for options while watching TV?
January 10, 2026 at 12:44 AM
rimagev.bsky.social
I just saw this commercial for Cobenfy, a drug for schizophrenia.

Then I thought "Cobenfy, Covfefe......."
January 9, 2026 at 3:40 AM
allaroundswell.bsky.social
For the life of me I can't figure out why Bristol Meyers Squibb picked such a loser to be the face of their Cobenfy ad campaign
January 5, 2026 at 1:55 PM
seancbass.bsky.social
No way Cobenfy guy’s playlist is gonna match the vibe of that neighborhood cookout.
January 5, 2026 at 4:57 AM
boozybadger.lawyersandliquor.com
The ad for the schizophrenia medication, Cobenfy, has the afflicted individual breaking the fourth wall at the end of the ad.

…
January 2, 2026 at 11:04 PM
bren-dazzle11.bsky.social
Remember when the idiot posted "covfefe"? We know he can't pronounce anything & always gives away his secrets. What if he meant Cobenfy, the schizophrenia drug. It could have been added to his meds and it was on his mind. It would explain his constant "everyone tells me", he has the symptoms.🤪
December 29, 2025 at 3:45 PM
ie-news.bsky.social
Southern California Psychiatry: Review of New Agents in Schizophrenia and Dementia

https://www.europesays.com/ie/254461/

Toward a Muscarinic Agent Solution for the Presynaptic Dopamine Problem in Schizophrenia Research on Cobenfy (xanomeline-trospium) presents a…
Southern California Psychiatry: Review of New Agents in Schizophrenia and Dementia - Ireland
Toward a Muscarinic Agent Solution for the Presynaptic Dopamine Problem in Schizophrenia
www.europesays.com
December 27, 2025 at 6:45 PM
us-ca-nb.bsky.social
Southern California Psychiatry: Review of New Agents in Schizophrenia and Dementia

https://www.newsbeep.com/us-ca/110382/

Toward a Muscarinic Agent Solution for the Presynaptic Dopamine Problem in Schizophrenia Research on Cobenfy (xanomeline-trospium) presents a…
Southern California Psychiatry: Review of New Agents in Schizophrenia and Dementia - California News Beep
Toward a Muscarinic Agent Solution for the Presynaptic Dopamine Problem in Schizophrenia
www.newsbeep.com
December 27, 2025 at 4:20 PM
ccdude8.bsky.social
#Boycott @cbsnews.com Top 10 Advertisers

Teva Neuroscience Inc. (Austedo XR product)
Bristol-Myers Squibb Company (Cobenfy product)
AstraZeneca (Breztri product)
AbbVie Inc. (Rinvoq product)
Allstate Insurance Company
WeatherTech products
Gold Bond products
Procter & Gamble
Amazon
Ferrero Group
deanobeidallah.bsky.social Dean Obeidallah @deanobeidallah.bsky.social · Dec 23
If you read memo from Bari Weiss on 60 Minutes segment on El Salvador prison she killed, you understand she will be censoring every single news segment on 60 Minutes and CBS News. All segments must line up with her right wing political views or be killed. www.mediaite.com/media/news/r...
READ: Bari Weiss Laid Out ‘Specific’ Issues with 60 Minutes CECOT Report in Leaked Memo Before Yanking Segment
In the leaked memo Bari Weiss argues that the 60 Minutes segment she pulled this week’s show required more context and balance and was not broadcast-ready.
www.mediaite.com
December 23, 2025 at 11:54 PM
leftylady.bsky.social
Consistent advertisers w/CBS & Paramount Global:
Pharma like AbbVie Inc. (Rinvoq, Humira), Bristol-Myers Squibb (Cobenfy), & AstraZeneca (Breztri).
Large retailers & tech companies such as Amazon & Procter & Gamble.
Insurance & financial services like Allstate, Progressive, & Fidelity Investments.
December 23, 2025 at 8:01 PM
stocktitan.net
#ZLAB Zai Lab Announces Approval of COBENFY (xanomeline and trospium chloride) in China, a First-in-Class Therapy for Schizophrenia

https://www.stocktitan.net/news/ZLAB/zai-lab-announces-approval-of-cobenfy-xanomeline-and-trospium-d3a9ukolj8nt.html
Zai Lab Announces Approval of COBENFY (xanomeline and trospium chloride) in China, a First-in-Class Therapy for Schizophrenia
Zai Lab (NASDAQ: ZLAB) announced that China’s National Medical Products Administration approved COBENFY (xanomeline and trospium chloride) for treatment of schizophrenia in adults on December 23, 2025. COBENFY is described as the first schizophrenia therapy with a novel mechanism in over 70 years, selectively activating M1 and M4 receptors. Approval is supported by a China Phase 1 PK study, the Phase 3 China study ZL-2701-001, and three global EMERGENT studies. COBENFY was also included in China’s national schizophrenia guidelines (2025 edition).
www.stocktitan.net
December 23, 2025 at 12:30 PM
everythirdthought.bsky.social
That sucks. Thank you. The medication is Cobenfy for paranoid schizophrenia. I am on Medicare and Medicaid
December 21, 2025 at 10:03 PM
vanguardbehavioral.bsky.social
For 70 years, every schizophrenia medication worked the same way - with the same severe side effects that made people quit treatment.
The FDA just approved Cobenfy: a different mechanism, fewer side effects, real hope.
Read more: vanguardbehavioral.com/new-schizophrenia-medication-breakthrough-hope
December 20, 2025 at 3:41 PM
eu-health.bsky.social
FDA dings Bristol Myers Squibb, Karuna over TV ad for Cobenfy – MM+M

https://www.europesays.com/uk/643011/

Bristol Myers Squibb and its subsidiary Karuna Therapeutics received the latest Untitled Letter from the Food and Drug…
FDA dings Bristol Myers Squibb, Karuna over TV ad for Cobenfy - MM+M - United Kingdom
Bristol Myers Squibb and its subsidiary Karuna Therapeutics received the latest Untitled Letter from the Food and Drug Administration earlier this week.
www.europesays.com
December 19, 2025 at 10:40 PM
us-nb.bsky.social
FDA dings Bristol Myers Squibb, Karuna over TV ad for Cobenfy – MM+M

https://www.newsbeep.com/us/358761/

Bristol Myers Squibb and its subsidiary Karuna Therapeutics received the latest Untitled Letter from the Food and Drug…
FDA dings Bristol Myers Squibb, Karuna over TV ad for Cobenfy - MM+M - United States News Beep
Bristol Myers Squibb and its subsidiary Karuna Therapeutics received the latest Untitled Letter from the Food and Drug Administration earlier this week.
www.newsbeep.com
December 19, 2025 at 9:48 PM
ie-news.bsky.social
FDA dings Bristol Myers Squibb, Karuna over TV ad for Cobenfy – MM+M

https://www.europesays.com/ie/241615/

Bristol Myers Squibb and its subsidiary Karuna Therapeutics received the latest Untitled Letter from the Food and Drug…
FDA dings Bristol Myers Squibb, Karuna over TV ad for Cobenfy - MM+M - Ireland
Bristol Myers Squibb and its subsidiary Karuna Therapeutics received the latest Untitled Letter from the Food and Drug Administration earlier this week.
www.europesays.com
December 19, 2025 at 9:15 PM